- Home
- Gastroenterology
- Fidaxomicin as a First-Line Option to Reduce Recurrence in Clostridioides difficile Infection
2mo3 min read
Medical Article
Introduction Clostridioides difficile infection (CDI) is the leading cause of healthcare-associated infectious diarrhoea worldwide (1). The burden is substantial, with over 500,000 cases annually in the United States alone and significant mortality among hospitalized and elderly populations (1). Although several antibiotics achieve initial resoluti

Fidaxomicin as a First-Line Option to Reduce Recurrence in Clostridioides difficile Infection
896 Reached4 Comments
Similar Content

Woman presented with Fever of Unknown Origin
7731 Reached93 Comments19 Likes

Use of Clindamycin for Managing Bacterial Vaginosis
11211 Reached29 Comments8 Likes

Chronic Hyperplastic Candidiasis Of The Oral Mucosa
858 Reached9 Comments11 Likes

Case of Adolescent with Severe Macrocytic Anaemia
52903 Reached502 Comments51 Likes

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes
